General Archive
-
ArticlesLifeArc supports research to develop a quick, affordable blood test for the early detection of dementia
As part of a collaboration with UK Dementia Research Institute, we are supporting research to validate a new blood test…
-
BlogsReflections from the LifeArc Translational Science Summit on MND and Rare Dementias
On 5 March 2025, we hosted a Translational Science Summit on MND and Rare Dementias. From leading researchers, to venture…
-
News releasesLifeArc and Neuropeutics Inc join forces to advance a new treatment for MND/ALS
LifeArc has announced a collaboration with Neuropeutics Inc to develop a new small molecule for the treatment of motor neuron…
-
Neuropeutics Inc: A partnership to advance treatment for MND/ALS
Neuropeutics Inc: A partnership to advance treatment for MND/ALS We are collaborating with Neuropeutics Inc to develop a small molecule…
-
LifeArc Translational Science Summit on MND and Rare Dementias
About the event The LifeArc Translational Science Summit on MND and Rare Dementias will showcase LifeArc’s innovative work and expert…
-
News releasesThird global Longitude Prize to be launched in 2025 focusing on ALS
A LifeArc-funded prize to incentivise the use of AI and machine-learning approaches in drug discovery for ALS, a form of…
-
MND biomarker roadmap report
LifeArc convened a group of experts from the MND biomarker community for a roundtable event, discussing the challenges holding us…
-
MND Insights report
At LifeArc, we know from experience that for medical research to be most effective, it is vital that the people…
-
MND International Symposium
About the event The International Symposium is the biggest annual conference dedicated to ALS and MND research. Each year it…
-
ALS TDI: Advancing ALS/MND prognosis, monitoring, and drug development
ALS TDI: Advancing ALS/MND prognosis, monitoring, and drug development We are collaborating with the ALS Therapy Development Institute (ALS TDI)…
-
MND STaR: Validating therapeutic targets for motor neuron disease with King’s College London
Validating therapeutic targets for motor neuron disease with King’s College London We have teamed up with King’s College London (King’s)…
-
News releases
£76M investment backing into potential MND treatment, underlines benefit of charity funding
Promising new research to develop gene therapy to treat motor neuron disease and other conditions like dementia secures big investment…